Joanna Cosgrove09.22.11
The rising prevalence of obesity, coupled with the increased incidence of obesity-related health conditions like diabetes and cardiovascular disease, is poised to have a momentous effect on healthcare spending, costing some states upwards of $15 billion per year.
The dietary supplement market is flush with products claiming to assist with weight loss but Conjugated Linoleic Acid (CLA) is one popular weight management ingredient with Generally Recognized as Safe (GRAS) status that has steadily resonated with consumers—so much so that the market for CLA is projected to exceed $199 million by 2017, according to a report from Global Industry Analysts, Inc. of San Jose, CA.
"Conjugated Linoleic Acid (CLA): A Global Strategic Business Report" stated that the CLA market is perceived to be “a panacea for several modern-day ills,” driven primarily by the rising incidence of obesity among adults/children and consumer demand for safe and effective weight reduct
FREE SUBSCRIPTION
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
